Why did Aditxt turn to Crypto.com to secure its biotech treasury? Aditxt Crypto.com Aditxt, a social innovation platform advancing health technologies, signed an agreement with Crypto.com to establish a custodial crypto account. The move supports its plan to back biotech innovation with a digital asset reserve including Bitcoin. Under the agreement Crypto.com will serve as custodian for Aditxt’s proposed digital treasury, using its institutional‑grade Crypto.com Custody service. Aditxt common stock also becomes tradable via Crypto.com’s broker‑dealer, enabling easier access for crypto‑native investors. Aditxt Crypto.com Crypto.com Crypto.com Crypto.com This signals an integration between biotech financing and digital asset infrastructure. Crypto.com’s platform offers custody services to institutions and high‑net‑worth clients via a secure, end‑to‑end solution. Crypto.com What is bitXbio and why does it matter? bitXbio is Aditxt’s crypto‑native social platform that aims to bridge financial technology and biotechnology. It supports access to innovations such as immune reprogramming (Adimune), early cancer detection (Pearsanta), and women’s health (Adifem). By anchoring biotech projects in a digital treasury and enabling trading of its stock via Crypto.com, Aditxt aligns its health innovation mission with next‑generation finance. Crypto.com What do the executives say? Eric Anziani, President and COO of Crypto.com, said that businesses are planning for the future with digital asset treasuries and that the company is pleased to support Aditxt’s bitXbio initiative with best‑in‑class custody as they engage crypto‑native traders. Crypto.com Amro Albanna, Co‑founder and CEO of Aditxt, described the agreement as a key step in aligning biotech assets with next‑generation financial infrastructure. He said the partnership lays the foundation for a platform where value is created through innovation and made accessible through digital finance. Final Outlook This agreement between Aditxt and Crypto.com represents a novel crossroads of biotechnology and cryptocurrency. It offers a glimpse of how digital asset platforms might support early‑stage health innovation with greater transparency and access. Crypto.com On the positive side, placing digital assets like Bitcoin into a biotech treasury could democratize funding and attract new classes of investors. It also streamlines equity access via a trusted custody service. However, integrating volatile crypto assets into financing models introduces market risk. Aditxt must manage fluctuating valuations and regulatory complexity. The success of this strategy depends on its ability to raise sufficient capital for its biotech pipeline and close deals such as its proposed acquisition of Evofem, expected by the second half of 2025. My view is that Aditxt’s move is bold and forward-looking, blending innovation domains. If executed carefully, it could inspire other health tech firms to explore similar models. But oversight, risk management, and regulatory clarity will be essential to make this a sustainable path. Don’t forget to like and share the story! This author is an independent contributor publishing via our business blogging program. HackerNoon has reviewed the report for quality, but the claims herein belong to the author. #DYO This author is an independent contributor publishing via our business blogging program. HackerNoon has reviewed the report for quality, but the claims herein belong to the author. #DYO This author is an independent contributor publishing via our business blogging program. HackerNoon has reviewed the report for quality, but the claims herein belong to the author. #DYO business blogging program business blogging program

This story contains new, firsthand information uncovered by the writer.

The writer was physically present in relevant location(s) to this story. The location is also a prevalent aspect of this story be it news or otherwise.

Hot off the press! This story contains factual information about a recent event.

Bitcoin

How Aditxt and Crypto.com are Bridging Biotech and Crypto Finance

About Author

Comments

TOPICS

THIS ARTICLE WAS FEATURED IN

Related Stories

$2M Backing and a Vision: How GAM3S.GG is Reshaping Web3 Gaming

5 Unexpected Industries Ripe for 3D Printing Disruption

Animal Cloning and New Drugs: How Biotech Works

Bodymind Operating Systems

Gene-Modified Babies: Essentials of the Bioethics Subjecting 'Designer-Babies' for Future Parents

Hacking Synthetic Biology with Noonies Nominee Kahlil Corazo

$2M Backing and a Vision: How GAM3S.GG is Reshaping Web3 Gaming

5 Unexpected Industries Ripe for 3D Printing Disruption

Animal Cloning and New Drugs: How Biotech Works

Bodymind Operating Systems

Gene-Modified Babies: Essentials of the Bioethics Subjecting 'Designer-Babies' for Future Parents

Hacking Synthetic Biology with Noonies Nominee Kahlil Corazo

Light-Mode

Classic

Newspaper

Dark-Mode

Neon Noir

Minty

HN StartUps